The SARS-CoV-2 Neutralizing antibody Test Kit is suitable for in vitro qualitative detection of SARS-CoV-2 neutralizing antibodies in human serum samples. SARS-CoV-2 Neutralizing antibody is an important marker for assessing the effectiveness of the new coronavirus vaccines. This reagent is suitable for neutralizing antibody detection in samples from individuals with vaccine injection and recovered persons. SARS-CoV-2 Neutralizing antibody Test Kit is of great significance for the development of new coronavirus vaccines, evaluation of effectiveness, and evaluation of neutralizing antibody levels in the population.
With the global pandemic of the novel coronavirus disease (COVID-19), the number of infections and deaths continues to rise, and scientists from various countries are constantly looking for treatments for COVID-19. For the prevention of sudden major infectious diseases, neutralizing antibody therapy is an important strategy for effective prevention and treatment. Neutralizing antibodies are a kind of soluble protein secreted by adaptive immune response cells, ii can recognize the virus surface protein and prevent it from binding to cell receptors. After the virus invades the human body, immune cells secrete neutralizing proteins into the blood. These antibodies prevent the virus from infecting cells by binding to the spike protein on the surface of the virus. Neutralizing Antibodies are expected to become a sharp edge against the novel coronavirus disease.
LFIA METHOD OVERVIEW: